Last reviewed · How we verify
NCT06837181: SPeCTRuM
Studying the Presence of CFRD Complications With Thoughtful Recruitment (SPeCTRuM)
trial testing observational study in Cystic Fibrosis (CF) in 200 participants. Currently enrolling.
30 November 2028
Quick facts
| Lead sponsor | Jaeb Center for Health Research |
|---|---|
| Status | Recruiting now |
| Study type | OBSERVATIONAL |
| Enrollment | 200 |
| Start date | 18 September 2025 |
| Primary completion | 30 November 2028 |
| Estimated completion | 30 November 2028 |
| Sites | 18 locations across United States |
Drugs / interventions tested
- observational study — full drug profile →
Conditions studied
- Cystic Fibrosis (CF) — all drugs for Cystic Fibrosis (CF) →
- Cystic Fibrosis-related Diabetes — all drugs for Cystic Fibrosis-related Diabetes →
- Diabetes — all drugs for Diabetes →
- Retinopathy — all drugs for Retinopathy →
Sponsor
Jaeb Center for Health Research — full company profile →
Who can join
12 and older, any sex, with Cystic Fibrosis (CF) or Cystic Fibrosis-related Diabetes. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This multicenter cross-sectional study will include a diverse population of adolescents and adults with CF. The overall Aim is to describe prevalence of diabetes microvascular complications and macrovascular surrogates in people with established CFRD.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06837181
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of observational study
Trials testing the same drug.
- NCT07497139 — Sepsis Induced Myocardial Injury in Critically Ill Children · not yet recruiting
- NCT07379567 — BREVOC Study: Exhaled VOCs for High-Risk Chest Pain in the ED · not yet recruiting
- NCT07391007 — Integrated Clinical-molecular Risk Stratification to Early Recurrence in Colorectal Liver Metastases · not yet recruiting
- NCT07372183 — Wound Healing Following Extraction and Ridge Preservation in Smokers and Non-smokers · not yet recruiting
- NCT07310186 — Treatment and Outcomes of DLBCL After Progression on Polatuzumab Vedotin-based Combination Therapy · not yet recruiting
Other recruiting trials for Cystic Fibrosis (CF)
Currently open trials in the same condition.
- NCT07303621 — Population Pharmacokinetics of Elexacaftor-tezacaftor-ivacaftor in a Paediatric Population · recruiting
- NCT07071324 — CF Wellness Program · NA · recruiting
- NCT07083557 — Routine Validation and Reproducibility Testing of Laboratory Assays and Research Techniques Used for Endocrine, Cardiome · recruiting
- NCT07363304 — Impact of Elexacaftor-Tezacaftor-Ivacaftor Treatment on Metabolic, Epigenetic and Fecal Microbiota Profiles in People Wi · recruiting
- NCT07508904 — Exercises' Effect on Muscle Strength, Aerobic Capacity and Respiratory Functions in Cystic Fibrosis · NA · recruiting
Other Jaeb Center for Health Research trials
Trials by the same sponsor.
- NCT07496515 — Omega-3 Supplementation vs Demodex vs Eyelid Cleanser for Pediatric Chalazia · Phase 2 · not yet recruiting
- NCT07095894 — A RCT of Spectacles With Aspherical Lenslets or 0.05% Atropine for Myopia Control · Phase 3 · not yet recruiting
- NCT06880835 — Effect of Inhaled Technosphere Insulin vs RAA Insulin on Exercise-Induced Hypoglycemia in Adults With T1D Using Automate · NA · recruiting
- NCT06957028 — CGM for the Early Detection and Management of Hyperglycemia in Pregnancy · NA · recruiting
- NCT06524882 — Dichoptic Treatment for Amblyopia in Children 8 to 12 Years of Age · Phase 3 · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06837181 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Jaeb Center for Health Research
- Last refreshed: 10 February 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06837181.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing